LATEST NEWS: 27 May 2025 A team of five intrepid trekkers are getting ready to hike the arduous 96 km Kokoda Trail next month to raise funds for TROG Cancer Research, driven by the desire to honour Australia’s WWII soldiers while making a difference to the lives of those
LATEST NEWS: 27 MAY 2025 TROG members and staff marked Clinical Trials Day 2025 on 20 May with a range of colourful celebrations, highlighting the crucial value of clinical trials to advance medical science, including in the area of radiation therapy. The annual day is an opportunity to recognise
MEDIA RELEASE: 20 MAY 2025 The world-leading impact of a Newcastle-based cancer research organisation is in the spotlight this International Clinical Trials Day (Tuesday 20 May), after funding was granted for groundbreaking new research projects. The Trans Tasman Radiation Oncology Group –TROG Cancer Research – has been leading radiation
LATEST NEWS: 15 May 2025 A novel imaging modality aimed at reducing radiation therapy side effects for patients with lung cancer is set to be trialled in Australia, after researchers received a $1.86m National Health and Medical Research Council (NHMRC) grant. The NHMRC Clinical Trials and Cohort Studies Grant
Latest News: 21 April 2025 TROG Cancer Research is among 70 research bodies in Australia that are supporting a national initiative to make existing health and medical research data easier to find, boosting secondary use of valuable clinical trials research data. The Health Studies Australian National Data Asset (HeSANDA)
INTERVIEW: 9 April 2025 Professor Bryan Burmeister is one of TROG’s longest standing members, who has contributed to our work in a myriad of ways over the past 30 years. He was TROG Scientific Committee Chair from 2002-2007, Board President from 2007 to 2010 and has led multiple trials.
Latest news: 28 March 2025. TROG Members who have made significant contributions both to the work of TROG and to advancing radiation medicine clinical trial research more broadly were recognised with our 2025 Research Excellence Awards this month. We congratulate the following winners on their well-deserved awards, which were
9 January 2025: Two important TROG Cancer Research trials investigating liver cancer and brain metastases resulting from other advanced cancers are set to progress to the next level, after successfully gaining a total of $250,000 in grants from the Tour de Cure cancer charity. Tackling hepatocellular cancer The TROG
7 January 2025: TROG Cancer Research is advancing vital cancer research, with the support of a generous $300,000 donation from the GenesisCare Foundation. The donation will support TROG’s work to promote the prevention and control of cancer through cancer research, in line with our objectives, mission and strategic goals
28 November 2024: In this Q&A, TROG President A/Prof Puma Sundaresan talks about her passion for patient-centred cancer care, her vision for TROG and future directions for radiation medicine research. Q: What attracted you to the field of radiation oncology, and drives your continued passion for this field? A:
For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.
Latest News
Keep up to date with TROG news, subscribe to our community newsletter.
ABN: 45 132 672 292
